论文信息 - 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chairperson) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. Banning (UK), Umberto Benedetto (UK), Robert A. Byrne (Germany), Jean-Philippe Collet (France), Volkmar Falk (Germany), Stuart J. Head (The Netherlands), Peter Jüni (Canada), Adnan Kastrati (Germany), Akos Koller (Hungary), Steen D. Kristensen (Denmark), Josef Niebauer (Austria), Dimitrios J. Richter (Greece), Petar M. Seferovi c (Serbia), Dirk Sibbing (Germany), Giulio G. Stefanini (Italy), Stephan Windecker (Switzerland), Rashmi Yadav (UK), Michael O. Zembala (Poland) Document Reviewers: William Wijns (ESC Review Co-ordinator) (Ireland), David Glineur (EACTS Review Co-ordinator) (Canada), Victor Aboyans (France), Stephan Achenbach (Germany), Stefan Agewall (Norway), Felicita Andreotti (Italy), Emanuele Barbato (Italy), Andreas Baumbach (UK), James Brophy (Canada), Héctor Bueno (Spain), Patrick A. Calvert (UK), Davide Capodanno (Italy), Piroze M. Davierwala

[1] A Kantrowitz,et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. , 1968, JAMA.

[2] J. Cohn,et al. Right ventricular infarction. Clinical and hemodynamic features. , 1974, The American journal of cardiology.

[3] V. Rissanen. Occurrence of coronary ostial stenosis in a necropsy series of myocardial infarction, sudden death, and violent death. , 1975, British heart journal.

[4] A. Grüntzig. TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS , 1978, The Lancet.

[5] R. Dinsmore,et al. Right ventricular infarction. Clinical diagnosis and differentiation from cardiac tamponade and pericardial constriction. , 1974, The American journal of cardiology.

[6] R. O'rourke,et al. Right ventricular infarction: identification by hemodynamic measurements before and after volume loading and correlation with noninvasive techniques. , 1984, Journal of the American College of Cardiology.

[7] Cass Principal Investigators and Their Associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.

[8] E. Passamani,et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. , 1985, The New England journal of medicine.

[9] W. C. Sheldon,et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[10] R. Thompson. Isolated coronary ostial stenosis in women. , 1986, Journal of the American College of Cardiology.

[11] B. Gersh,et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. , 1986, Circulation.

[12] G. Miller,et al. Isolated coronary ostial stenosis. , 1986, Catheterization and cardiovascular diagnosis.

[13] W. Edwards,et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. , 1987, Journal of the American College of Cardiology.

[14] H. Barner,et al. Coronary Ostial Stenosis , 1975, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15] G. E. Green,et al. Clinical implications of internal mammary artery bypass grafts: the Coronary Artery Surgery Study experience. , 1988, Circulation.

[16] J. Matloff,et al. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. , 1988, The Journal of thoracic and cardiovascular surgery.

[17] M. Scott,et al. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery. , 1990, BMJ.

[18] M. Knudsen,et al. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. , 1990, The Journal of thoracic and cardiovascular surgery.

[19] A. Jaffe,et al. Determinants of hemodynamic compromise with severe right ventricular infarction. , 1990, Circulation.

[20] E. Topol,et al. Atherectomy of right coronary ostial stenoses: initial and long-term results, technical features and histologic findings. , 1991, The American journal of cardiology.

[21] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[22] H. Hecht,et al. Lesion morphology and coronary angioplasty: current experience and analysis. , 1992, Journal of the American College of Cardiology.

[23] P. Hartigan,et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.

[24] J. López-Sendón,et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. , 1992, Journal of the American College of Cardiology.

[25] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[26] RITA-2 trial participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[27] M. Leon,et al. Rotational coronary atherectomy of ostial stenoses. , 1993, The American journal of cardiology.

[28] L. Wallentin,et al. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. , 1993, International journal of cardiology.

[29] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[30] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[31] B. Iung,et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. , 1993, The Journal of heart valve disease.

[32] E. Topol,et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.

[33] F. Loop,et al. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. , 1994, The Journal of thoracic and cardiovascular surgery.

[34] M. Kutner,et al. A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[35] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[36] D. Baker,et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. , 1994, JAMA.

[37] C. Hamm,et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[38] B. Chaitman,et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. , 1995, Circulation.

[39] CABRI Trial Participants,et al. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) , 1995, The Lancet.

[40] B. Chaitman,et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. , 1995, Circulation.

[41] C. White,et al. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[42] Eric Boersma,et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.

[43] R. Califf,et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. , 1996, The Journal of thoracic and cardiovascular surgery.

[44] M. Whooley,et al. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. , 1997, JAMA.

[45] M. Hadamitzky,et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[46] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[47] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[48] David Schultz,et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[49] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[50] R. Califf,et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.

[51] U. Sigwart,et al. Cutting balloon angioplasty and stenting for aorto-ostial lesions. , 1997, Heart.

[52] Bigger Jt,et al. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[53] W. O’Neill,et al. Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. , 1997, Catheterization and cardiovascular diagnosis.

[54] RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.

[55] E. Blackstone,et al. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. K.U. Leuven Coronary Surgery Program. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[56] N. Geller,et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[57] J. Dhainaut,et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[58] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[59] C. Dennis,et al. The Electrocardiographic Exercise Test in a Population with Reduced Workup Bias: Diagnostic Performance, Computerized Interpretation, and Multivariable Prediction , 1998, Annals of Internal Medicine.

[60] S. Pocock,et al. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[61] K. Wegscheider,et al. Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis. , 1998, Journal of the American College of Cardiology.

[62] A. Kastrati,et al. Operator volume and outcome of patients undergoing coronary stent placement. , 1998, Journal of the American College of Cardiology.

[63] Alan M. Johnson,et al. Port-access coronary artery bypass grafting: technique and comparative results. , 1999, The Annals of thoracic surgery.

[64] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[65] H. Schäfers,et al. T grafts with the right internal thoracic artery to left internal thoracic artery versus the left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery main stem. , 1999, The Journal of thoracic and cardiovascular surgery.

[66] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[67] J. Cox,et al. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. , 1999, The Journal of thoracic and cardiovascular surgery.

[68] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[69] D. Waters,et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[70] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[71] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[72] S. Lemeshow,et al. European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[73] T. Muramatsu,et al. Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. , 1999, The Journal of invasive cardiology.

[74] S. Nashef,et al. Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .

[75] T Walther,et al. Comparison of MIDCAP versus conventional CABG surgery regarding pain and quality of life. , 1999, The heart surgery forum.

[76] F. Loop,et al. Surgery for Acquired Cardiovascular DiseaseIsolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: Late consequences of incomplete revascularization☆☆☆ , 2000 .

[77] G. O'connor,et al. Risks of Morbidity and Mortality in Dialysis Patients Undergoing Coronary Artery Bypass Surgery , 2000, Circulation.

[78] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[79] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.

[80] V. Ho,et al. Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. , 2000, Circulation.

[81] H A Feldman,et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. , 2000, JAMA.

[82] H. Roskamm,et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. , 2000, Circulation.

[83] V. Fuster,et al. Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus , 2000, Circulation.

[84] J. Hochman,et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? , 2000, Journal of the American College of Cardiology.

[85] M. Bourassa,et al. Management of coronary artery disease: therapeutic options in patients with diabetes. , 2000, Journal of the American College of Cardiology.

[86] M. Galli. [Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[87] G. Guyatt,et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials , 2000, BMJ : British Medical Journal.

[88] Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000 .

[89] S. Yusuf,et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis , 2000, The Lancet.

[90] T. Ryan,et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. , 2000, JAMA.

[91] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[92] S. Yusuf,et al. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.

[93] P. Steg,et al. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. , 2000, International journal of cardiology.

[94] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.

[95] H. White,et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[96] L. Sleeper,et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[97] R. Califf,et al. Lack of progress in cardiogenic shock: lessons from the GUSTO trials , 2000 .

[98] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[99] Douglas G Altman,et al. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries , 2001, The Lancet.

[100] Salim Yusuf,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.

[101] A. Kastrati,et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. , 2003, Journal of the American College of Cardiology.

[102] B. Lytle. Skeletonized internal thoracic artery grafts and wound complications. , 2001, The Journal of thoracic and cardiovascular surgery.

[103] W Wijns,et al. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.

[104] A. Liberati,et al. The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. , 2001, European heart journal.

[105] L. D. Saunders,et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. , 2001, American heart journal.

[106] I. Palacios,et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. , 2001, Journal of the American College of Cardiology.

[107] K. Detre,et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.

[108] Effect of carvedilol on survival in severe chronic heart failure. , 2001 .

[109] C. Tracy,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[110] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.

[111] D. Exner,et al. Prior Coronary Artery Bypass Surgery and Risk of Death Among Patients With Ischemic Left Ventricular Dysfunction , 2001, Circulation.

[112] Mitchell W. Krucoff,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.

[113] E. Braunwald,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[114] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.

[115] F Unger,et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[116] P. Ducimetiere,et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. , 2001, Journal of the American College of Cardiology.

[117] G. Pasterkamp,et al. Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[118] A. Serra,et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.

[119] J. Lasala,et al. Randomized Comparison of Ticlopidine and Clopidogrel After Intracoronary Stent Implantation in a Broad Patient Population , 2001, Circulation.

[120] J. Birkmeyer,et al. Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. , 2001, Surgery.

[121] The Time Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.

[122] P. Pellikka,et al. Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. , 2001, The American journal of medicine.

[123] Volume-Outcome Relation for Physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State , 2002 .

[124] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[125] M. Leon,et al. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[126] Joseph P Desimone,et al. Long-term survival of dialysis patients after coronary bypass grafting. , 2002, The Annals of thoracic surgery.

[127] A. Connor,et al. The way I see it: House officers need formal career development , 2002 .

[128] S. Marsch,et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[129] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[130] J. López-Sendón,et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. , 2002, Journal of the American College of Cardiology.

[131] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.

[132] E. Amsterdam,et al. Immediate Exercise Testing to Evaluate Low‐Risk Patients Presenting to the Emergency Department with Chest Pain. , 2002, Journal of the American College of Cardiology.

[133] Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease , 2002 .

[134] Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery A Meta-Analysis , 2002 .

[135] Jiang He,et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[136] R. Califf,et al. Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.

[137] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[138] Thomas L. Lenz,et al. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. , 2002, Chest.

[139] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[140] L. Schwartz,et al. The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions. , 2002, The Journal of invasive cardiology.

[141] J. Goldstein. Pathophysiology and management of right heart ischemia. , 2002, Journal of the American College of Cardiology.

[142] S. Ellis,et al. Emergency Coronary Artery Bypass Surgery in the Contemporary Percutaneous Coronary Intervention Era , 2002, Circulation.

[143] M. Dashwood,et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. , 2002, The Annals of thoracic surgery.

[144] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[145] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[146] Deepak L. Bhatt,et al. Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials , 2002, Circulation.

[147] W. Boden,et al. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. , 2002, Journal of the American College of Cardiology.

[148] Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002 .

[149] L. Shaw,et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[150] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[151] Jerome Sacks,et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. , 2002, Journal of the American College of Cardiology.

[152] L. Shaw,et al. Prognostic value of normal Tc-99m myoview SPECT imaging: preliminary results from the myoview multicenter registry in 4,728 patients , 2002 .

[153] Ameet Bakhai,et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.

[154] J. Birkmeyer,et al. Surgeon volume and operative mortality in the United States. , 2003, The New England journal of medicine.

[155] Deepak L. Bhatt,et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival , 2003 .

[156] Klaus Rasmussen,et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[157] L. Køber,et al. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. , 2003, European heart journal.

[158] Eugene Crystal,et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. , 2003, American heart journal.

[159] Diederick Grobbee,et al. Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty , 2003, Circulation.

[160] C. Di Mario,et al. Randomized Evaluation of Polytetrafluoroethylene‐Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial , 2003, Circulation.

[161] Sven-Göran Fransson,et al. Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[162] S. Nashef,et al. The logistic EuroSCORE , 2003 .

[163] P. Touboul,et al. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.

[164] S. Pocock,et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. , 2003, Journal of the American College of Cardiology.

[165] J. Bermejo,et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. , 2003, Journal of the American College of Cardiology.

[166] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[167] J. Tanigawa,et al. Comparison of cutting balloon vs stenting alone in small branch ostial lesions of native coronary arteries. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[168] U. Siebert,et al. Impact of intravascular ultrasound‐guided stenting on long‐term clinical outcome: A meta‐analysis of available studies comparing intravascular ultrasound‐guided and angiographically guided stenting , 2003 .

[169] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.

[170] A. Kastrati,et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.

[171] J. Critchley,et al. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[172] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[173] M. Dalby,et al. Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.

[174] G. Marenzi,et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[175] G. Stone,et al. Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.

[176] M. Pfisterer,et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. , 2003, JAMA.

[177] C. Macaya,et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. , 2003, Journal of the American College of Cardiology.

[178] J. Brophy,et al. Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis , 2003, Annals of Internal Medicine.

[179] P. Rothwell,et al. A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[180] P. Aspelin,et al. Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[181] J. Beckman,et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[182] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[183] E. Bonnefoy,et al. Primary angioplasty vs. prehospital fibrinolysis in acute myocardial infarction: a randomised study☆ , 2003 .

[184] Robert M Califf,et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.

[185] L. Sleeper,et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry , 2003 .

[186] C. Hofer,et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[187] L. Shaw,et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[188] D. Berman,et al. Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.

[189] U. Zeymer,et al. Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease: A Study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte , 2003, Circulation.

[190] A. Kastrati,et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003 .

[191] Eugenio Picano,et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. , 2003, Journal of the American College of Cardiology.

[192] H. White,et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.

[193] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[194] J. Ribeiro,et al. Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. , 2004, Arquivos brasileiros de cardiologia.

[195] R. Ferrari,et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. , 2004, Journal of the American College of Cardiology.

[196] F. Fernández‐Avilés,et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.

[197] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[198] O. Penn,et al. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[199] B. Gersh,et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. , 2004, Journal of the American College of Cardiology.

[200] M. Bonardi,et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study , 2004, International journal of cardiovascular interventions.

[201] Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. , 2004 .

[202] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[203] Christopher P Cannon,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[204] S. Ebrahim,et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[205] A. Kastrati,et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel , 2004 .

[206] H. Burri,et al. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[207] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[208] A. Kastrati,et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. , 2004, The New England journal of medicine.

[209] E. Topol,et al. Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. , 2004, European heart journal.

[210] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[211] F. A. Lucchese,et al. Efetividade do metoprolol na prevenção de fibrilação e flutter atrial no pós-operatório de cirurgia de revascularização miocárdica , 2004 .

[212] C David Naylor,et al. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. , 2004, The New England journal of medicine.

[213] R. Califf,et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[214] F. Loop,et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. , 2004, The Annals of thoracic surgery.

[215] M. Gottwik,et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). , 2004, European heart journal.

[216] E. DeLong,et al. Procedural volume as a marker of quality for CABG surgery. , 2004, JAMA.

[217] Thomas E. Moritz,et al. Coronary-artery revascularization before elective major vascular surgery. , 2004, The New England journal of medicine.

[218] Randall C. Thompson,et al. Predictors of Quality-of-Life Benefit After Percutaneous Coronary Intervention , 2004, Circulation.

[219] P. Poole‐Wilson,et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.

[220] B. Buxton,et al. Patencies of 2,127 arterial to coronary conduits over 15 years , 2004 .

[221] B. Hemmelgarn,et al. Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.

[222] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.

[223] S. Yusuf,et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. , 2004, The Cochrane database of systematic reviews.

[224] I. Iakovou,et al. CLINICAL RESEARCH Interventional Cardiology Clinical and Angiographic Outcome After Sirolimus- Eluting Stent Implantation in Aorto-Ostial Lesions , 2004 .

[225] A. Collins,et al. Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures , 2004, Circulation.

[226] P. Pellikka,et al. Prognostic value of exercise echocardiography in patients with classic angina pectoris. , 2004, The American journal of cardiology.

[227] E. Topol,et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. , 2004, JAMA.

[228] T. Harr,et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[229] R. Villareal,et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[230] H. Boshuizen,et al. Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.

[231] S. Assmann,et al. Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting After Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results From the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial , 2005, Circulation.

[232] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[233] Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005 .

[234] G. Schuler,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.

[235] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[236] J. Ioannidis,et al. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis , 2005, Circulation.

[237] P. Gaines,et al. The benefits of combined anti-platelet treatment in carotid artery stenting. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[238] G. Stone,et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.

[239] R. Christofferson,et al. Effect of chronic total coronary occlusion on treatment strategy. , 2005, The American journal of cardiology.

[240] S. Stevens,et al. for the REACT Trial Investigators. Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction , 2005 .

[241] P. Serruys,et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. , 2005, The American journal of cardiology.

[242] E. Tuzcu,et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease , 2005 .

[243] G. Schuler,et al. Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: A 5-Year Follow-Up , 2005, Circulation.

[244] A. Kastrati,et al. Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial , 2005, Circulation.

[245] P. Steg,et al. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. , 2005, The American journal of cardiology.

[246] Colin Baigent,et al. Low-dose aspirin for the prevention of atherothrombosis. , 2005, The New England journal of medicine.

[247] Antonio Colombo,et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. , 2005 .

[248] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[249] P. Serruys,et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). , 2005, American heart journal.

[250] Lisa Hartling,et al. Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.

[251] R. Gibbons,et al. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial , 2005 .

[252] Samin K. Sharma,et al. Volume-Outcome Relationships for Percutaneous Coronary Interventions in the Stent Era , 2005, Circulation.

[253] S. Stevens,et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. , 2005, The New England journal of medicine.

[254] G. Wells,et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). , 2005, Journal of the American College of Cardiology.

[255] R. Holloway,et al. Carotid endarterectomy—An evidence-based review , 2005, Neurology.

[256] K. Alexander,et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[257] Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials , 2005 .

[258] S. Stegher,et al. Dual Antiplatelet Regime Versus Acetyl-acetic Acid for Carotid Artery Stenting , 2006, CardioVascular and Interventional Radiology.

[259] Deepak L. Bhatt,et al. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). , 2005, The American journal of cardiology.

[260] B. Lytle,et al. Is reoperation still a risk factor in coronary artery bypass surgery? , 2005, The Annals of thoracic surgery.

[261] Prevent Iv Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .

[262] S. Nekolla,et al. Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial , 2005 .

[263] R. Habib,et al. Is hospital procedure volume a reliable marker of quality for coronary artery bypass surgery? A comparison of risk and propensity adjusted operative and midterm outcomes. , 2005, The Annals of thoracic surgery.

[264] Antonio Colombo,et al. Contemporary stent treatment of coronary bifurcations. , 2005 .

[265] A. Cohen-Solal,et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[266] H. Hein,et al. Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. , 2005, European heart journal.

[267] Yingxing Wu,et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. , 2005, The Journal of thoracic and cardiovascular surgery.

[268] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[269] E. Boersma,et al. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. , 2006, European heart journal.

[270] J. Boura,et al. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials , 2006, The Lancet.

[271] R. Erbel,et al. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[272] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[273] P. Poole‐Wilson,et al. Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease , 2006, Scandinavian cardiovascular journal : SCJ.

[274] P. Monteiro. Impact of Early Coronary Artery Bypass Graft in an Unselected Acute Coronary Syndrome Patient Population , 2006, Circulation.

[275] Deepak L. Bhatt,et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[276] E. Topol,et al. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. , 2006, European heart journal.

[277] A. Kastrati,et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. , 2006, JAMA.

[278] C. Di Mario,et al. Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[279] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[280] A. Pappalardo,et al. The impact of epiaortic ultrasonographic scanning on the risk of perioperative stroke. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[281] S. Bagshaw,et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. , 2006, The Annals of thoracic surgery.

[282] M. Graham,et al. Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. , 2006, The Canadian journal of cardiology.

[283] Samin K. Sharma,et al. Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[284] L. Mauri,et al. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. , 2006, American heart journal.

[285] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.

[286] H. Krumholz,et al. Relation Between Hospital Specialization With Primary Percutaneous Coronary Intervention and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction: National Registry of Myocardial Infarction-4 Analysis , 2006, Circulation.

[287] J. Critchley,et al. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[288] N. Smedira,et al. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. , 2006, The Journal of thoracic and cardiovascular surgery.

[289] R. Califf,et al. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. , 2006, Journal of the American College of Cardiology.

[290] Mark Stevenson,et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. , 2006, Health technology assessment.

[291] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.

[292] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[293] C. Macaya,et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. , 2006, Journal of the American College of Cardiology.

[294] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.

[295] Tom Treasure,et al. Off-Pump Surgery Is Associated With Reduced Occurrence of Stroke and Other Morbidity as Compared With Traditional Coronary Artery Bypass Grafting: A Meta-Analysis of Systematically Reviewed Trials , 2006, Stroke.

[296] R. Califf,et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. , 2006, The Annals of thoracic surgery.

[297] P. Serruys,et al. Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention , 2006, Circulation.

[298] D. Berman,et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. , 2006, Journal of the American College of Cardiology.

[299] J. Suárez de Lezo,et al. [A new classification of coronary bifurcation lesions]. , 2006, Revista espanola de cardiologia.

[300] P. Serruys,et al. Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[301] A. Keech,et al. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.

[302] E. Tsuchikane,et al. New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. , 2006, The Journal of invasive cardiology.

[303] G. Lamas,et al. Coronary intervention for persistent occlusion after myocardial infarction. , 2006, The New England journal of medicine.

[304] Harlan M Krumholz,et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. , 2006, The New England journal of medicine.

[305] D. Altman,et al. Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265] , 2006, Trials.

[306] A. Moss,et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.

[307] M. Böhm,et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2006, Clinical research in cardiology : official journal of the German Cardiac Society.

[308] M. Denvir,et al. Variations in clinical decision-making between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams? , 2006, Journal of cardiothoracic surgery.

[309] G. Montalescot,et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. , 2006, Journal of the American College of Cardiology.

[310] G. Maurer,et al. Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry) , 2006, Circulation.

[311] G. Montalescot,et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. , 2006, Journal of the American College of Cardiology.

[312] John D Friedman,et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[313] L. Wallentin,et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study , 2006, The Lancet.

[314] Jörg Hausleiter,et al. Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss , 2006, Circulation.

[315] P. Steg,et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry , 2006, Heart.

[316] J. Dunning,et al. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[317] F. Veglia,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of medicine.

[318] J. Brinker,et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[319] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. , 2006, The New England journal of medicine.

[320] M. Niemelä,et al. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study , 2006, Circulation.

[321] M. Morice,et al. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. , 2006, European heart journal.

[322] Jeroen J. Bax,et al. A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[323] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[324] J. Ware,et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. , 2007, JAMA.

[325] A. Ahlsson,et al. Postoperative atrial fibrillation is not correlated to C-reactive protein. , 2007, The Annals of thoracic surgery.

[326] J. Bergsland,et al. Transit time flowmetry in coronary surgery--an important tool in graft verification. , 2007, Bosnian journal of basic medical sciences.

[327] D. Berman,et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. , 2007, Journal of the American College of Cardiology.

[328] B. Brodie,et al. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. , 2007, The American journal of cardiology.

[329] Seung‐Jung Park,et al. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease. , 2007, The American journal of cardiology.

[330] Sebastian Kelle,et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.

[331] D. Taggart,et al. Gaseous and solid cerebral microembolization during proximal aortic anastomoses in off-pump coronary surgery: the effect of an aortic side-biting clamp and two clampless devices. , 2007, The Journal of thoracic and cardiovascular surgery.

[332] E. Rahme,et al. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. , 2007, The Annals of thoracic surgery.

[333] R. Carlos,et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[334] O. Penn,et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. , 2007, The Annals of thoracic surgery.

[335] Simon Wandel,et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.

[336] A. Schoenenberger,et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. , 2007, JAMA.

[337] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[338] C. Grines,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.

[339] R. Dietz,et al. Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) , 2007, Heart.

[340] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.

[341] C. Granger,et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. , 2007, Archives of internal medicine.

[342] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[343] W. Laskey,et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.

[344] R. Higgins,et al. Risk Index for Predicting In-Hospital Mortality for Cardiac Valve Surgery , 2007 .

[345] Bernard Chevalier,et al. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[346] S. Steinhubl,et al. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. , 2007, Archives of internal medicine.

[347] A. Moss,et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.

[348] Richard T. Lee,et al. Preoperative noncontrast chest computed tomography identifies potential aortic emboli. , 2007, The Annals of thoracic surgery.

[349] P. Lesault,et al. Six-Month Outcome of Emergency Percutaneous Coronary Intervention in Resuscitated Patients After Cardiac Arrest Complicating ST-Elevation Myocardial Infarction , 2007, Circulation.

[350] Timothy D. Henry,et al. A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.

[351] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[352] André Lamy,et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.

[353] B. Gersh,et al. Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2007 .

[354] Shaosong Zhang,et al. Strategies to reduce intraluminal clot formation in endoscopically harvested saphenous veins. , 2007, The Journal of thoracic and cardiovascular surgery.

[355] H. Krumholz,et al. Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications , 2007, Circulation.

[356] G. Mannam,et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. , 2007, The Journal of thoracic and cardiovascular surgery.

[357] J. Ware,et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[358] Reza Ardehali,et al. Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery , 2007, Annals of Internal Medicine.

[359] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[360] Ara Darzi,et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery , 2007, BMJ : British Medical Journal.

[361] Marco Valgimigli,et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.

[362] R. Virmani,et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. , 2007, Journal of the American College of Cardiology.

[363] Marco Valgimigli,et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[364] J. Dunning,et al. Does bilateral internal thoracic artery harvest increase the risk of mediastinitis? , 2007, Interactive cardiovascular and thoracic surgery.

[365] S. Yusuf,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. , 2007, Journal of the American College of Cardiology.

[366] A. Kastrati,et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. , 2007, Journal of the American College of Cardiology.

[367] C. Rogers,et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. , 2007, Journal of the American College of Cardiology.

[368] William Wijns,et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.

[369] B. Gersh,et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.

[370] A. Kastrati,et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. , 2008, The New England journal of medicine.

[371] A. Jaffe,et al. Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients , 2008, Circulation. Cardiovascular interventions.

[372] M. Hori,et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. , 2008, JACC. Cardiovascular interventions.

[373] Antonio Colombo,et al. Bifurcation disease: what do we know, what should we do? , 2008, JACC. Cardiovascular interventions.

[374] Mathias Prokop,et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. , 2008, Journal of the American College of Cardiology.

[375] F. Eberli,et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial , 2008, The Lancet.

[376] G. Lip,et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.

[377] N. Paul,et al. Perioperative β-Blockers : Use With Caution Perioperative β Blockers in Patients Having Non-Cardiac Surgery : A Meta-Analysis , 2010 .

[378] Michail I. Papafaklis,et al. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[379] A. van Rossum,et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.

[380] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.

[381] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.

[382] Adnan Kastrati,et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. , 2008, Journal of the American College of Cardiology.

[383] M. Banach,et al. Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival , 2008, Circulation.

[384] Stanley E. Kaufman,et al. Effect of PCI on quality of life in patients with stable coronary disease. , 2008, The New England journal of medicine.

[385] D. Mark,et al. Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) , 2008, Journal of cardiovascular electrophysiology.

[386] A. J. O’Malley,et al. Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients , 2008, Circulation.

[387] J. Ottervanger,et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial , 2008, The Lancet.

[388] G. Biondi-Zoccai,et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. , 2008, Journal of the American College of Cardiology.

[389] D. Vaughan,et al. Hybrid cardiovascular procedures. , 2008, JACC. Cardiovascular interventions.

[390] M. Böhm,et al. Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008 , 2008, Clinical Research in Cardiology.

[391] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[392] E. Steyerberg,et al. Do we need separate risk stratification models for hospital mortality after heart valve surgery? , 2008, The Annals of thoracic surgery.

[393] K. Kawazoe,et al. Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[394] F. Zijlstra,et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.

[395] D. Dudek,et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. , 2008, European heart journal.

[396] Deepak L. Bhatt,et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.

[397] M. Perez,et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. , 2008, JACC. Cardiovascular interventions.

[398] M. Budoff,et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Indi , 2008, Journal of the American College of Cardiology.

[399] G. Montalescot. Mechanical reperfusion: treat well, treat on time too , 2008, The Lancet.

[400] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[401] E. Topol,et al. Facilitated PCI in patients with ST-elevation myocardial infarction. , 2008, The New England journal of medicine.

[402] B. Gersh,et al. Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.

[403] A. Shah,et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.

[404] P. Kuchynka,et al. Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 , 2008, European heart journal.

[405] M. Flather,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.

[406] S. Jain,et al. Biodegradable-polymer-based, sirolimus-eluting Supralimus stent: 6-month angiographic and 30-month clinical follow-up results from the series I prospective study. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[407] Deepak L. Bhatt,et al. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. , 2008, European heart journal.

[408] M. Pfisterer,et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.

[409] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[410] S. Yusuf,et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.

[411] R. Mehta,et al. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. , 2008, The American journal of cardiology.

[412] Patrick W Serruys,et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.

[413] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[414] L. Rydén,et al. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. , 2007, European heart journal.

[415] E. Antman,et al. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 , 2008, Circulation.

[416] D. Yuh,et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. , 2008, The Journal of thoracic and cardiovascular surgery.

[417] Jeroen J. Bax,et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. , 2008, European heart journal.

[418] M. Fromm,et al. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.

[419] J. Boura,et al. Failed percutaneous coronary intervention: A decade of experience in 21,000 patients , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[420] A. Shroyer,et al. On-pump versus off-pump coronary-artery bypass surgery. , 2009, The New England journal of medicine.

[421] P. Myles,et al. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. , 2009, British journal of anaesthesia.

[422] P. Fitzgerald,et al. Prospective, Multicenter, Randomized Trial to ssess Efficacy of Pioglitazone on In-Stent eointimal Suppression in Type 2 Diabetes OPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study) , 2022 .

[423] F. Van de Werf,et al. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. , 2009, American heart journal.

[424] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[425] Alice Jacobs,et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. , 2009, JACC. Cardiovascular interventions.

[426] K. Thygesen,et al. How to set up an effective national primary angioplasty network: lessons learned from five European countries. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[427] C. Reid,et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. , 2009, The Annals of thoracic surgery.

[428] E. Antman,et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.

[429] G. Mancia,et al. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[430] J. Mega,et al. Abstract 2126: CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis , 2009 .

[431] G. Pelissero,et al. Risk of Assessing Mortality Risk in Elective Cardiac Operations: Age, Creatinine, Ejection Fraction, and the Law of Parsimony , 2009, Circulation.

[432] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[433] F. Fedele,et al. Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study , 2008, European heart journal.

[434] J. D. de Lemos,et al. Clinical ResearchInterventional CardiologyA Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions: The SOS (Stenting Of Saphenous Vein Grafts) Trial , 2009 .

[435] Thomas A Trikalinos,et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis , 2009, The Lancet.

[436] G. Montalescot,et al. Can we override clopidogrel resistance? , 2009, Circulation.

[437] F. Mohr,et al. Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.

[438] A. Ahlsson,et al. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality , 2009, Scandinavian cardiovascular journal : SCJ.

[439] W. Wijns,et al. On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. , 2009, JACC. Cardiovascular interventions.

[440] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.

[441] B. J. Gersh. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2009 .

[442] P. Armstrong,et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. , 2009, European heart journal.

[443] Deepak L. Bhatt,et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. , 2009, JAMA.

[444] Deepak L. Bhatt,et al. Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results From the Get With the Guidelines Program , 2009, Circulation.

[445] A. Kastrati,et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. , 2009, JACC. Cardiovascular interventions.

[446] Ralf Degenhardt,et al. Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis , 2009, Circulation.

[447] G. De Luca,et al. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials , 2009, European heart journal.

[448] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[449] N. Curzen,et al. Percutaneous coronary intervention of ostial lesions. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[450] Sean M. O'Brien,et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. , 2009, The Annals of thoracic surgery.

[451] Yuebing Li,et al. Strokes after cardiac surgery and relationship to carotid stenosis. , 2009, Archives of neurology.

[452] A. Kastrati,et al. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. , 2009, Journal of the American College of Cardiology.

[453] G. Ambrosio,et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. , 2009, Journal of the American College of Cardiology.

[454] V. Aboyans,et al. Indications for carotid screening in patients with coronary artery disease. , 2009, Presse medicale.

[455] J. Spertus,et al. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). , 2009, JACC. Cardiovascular interventions.

[456] R. Califf,et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. , 2009, The New England journal of medicine.

[457] H. Bøtker,et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. , 2009, European heart journal.

[458] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.

[459] R. Featherstone,et al. Randomized Controlled Trials Comparing Endarterectomy and Endovascular Treatment for Carotid Artery Stenosis: A Cochrane Systematic Review , 2009, Stroke.

[460] Deepak L. Bhatt,et al. Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial , 2009, Circulation.

[461] D. Bainbridge,et al. The Efficacy of an Intraoperative Cell Saver During Cardiac Surgery: A Meta-Analysis of Randomized Trials , 2009, Anesthesia and analgesia.

[462] Sunil V. Rao,et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.

[463] E. Hannan,et al. Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies , 2009, Circulation.

[464] J. Fajadet,et al. Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[465] H. Krumholz,et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. , 2009, Journal of the American College of Cardiology.

[466] Christopher M O'Connor,et al. Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.

[467] Young-Hak Kim,et al. Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.

[468] Regina M. Hardison,et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[469] B. Lytle,et al. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. , 2009, The Annals of thoracic surgery.

[470] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[471] J. Mega,et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial , 2009, The Lancet.

[472] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. , 2009, JACC. Cardiovascular interventions.

[473] J. Tijssen,et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2008, European heart journal.

[474] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.

[475] G. Schuler,et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. , 2008, European heart journal.

[476] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[477] A. Naylor. Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease? , 2009, The Journal of cardiovascular surgery.

[478] F. Fedele,et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. , 2009, Journal of the American College of Cardiology.

[479] Patrick W Serruys,et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods , 2009, The Lancet.

[480] J. Maselli,et al. Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery , 2009, Annals of Internal Medicine.

[481] T. Vassiliades,et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. , 2009, The Annals of thoracic surgery.

[482] P. Fitzgerald,et al. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. , 2009, Journal of the American College of Cardiology.

[483] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[484] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[485] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[486] G. Schuler,et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. , 2009, Journal of the American College of Cardiology.

[487] E. Topol,et al. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. , 2009, JACC. Cardiovascular interventions.

[488] F. Verheugt,et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.

[489] G. Baron,et al. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. , 2009, American heart journal.

[490] Stephan Willems,et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.

[491] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[492] P. Touboul,et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.

[493] E. Antman,et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis , 2009, Journal of the American College of Cardiology.

[494] John P A Ioannidis,et al. Double Versus Single Stenting for Coronary Bifurcation Lesions: A Meta-Analysis , 2009, Circulation. Cardiovascular interventions.

[495] M. Tendera,et al. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. , 2009, Journal of the American College of Cardiology.

[496] H. Calkins,et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. , 2009, Journal of the American College of Cardiology.

[497] G. Sangiorgi,et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.

[498] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[499] M. Vanderheyden,et al. Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery Stenosis , 2009, Circulation.

[500] G. Montalescot,et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.

[501] F. Neumann,et al. Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up: Results From the Prospective Multicenter German Cypher Registry , 2009, Circulation.

[502] Sunil V. Rao,et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[503] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[504] S. Nekolla,et al. Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial , 2009, Circulation.

[505] P. Serruys,et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.

[506] S. Khuri,et al. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. , 2009, The Annals of thoracic surgery.

[507] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[508] A. Kastrati,et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. , 2009, European heart journal.

[509] Sanjay Kaul,et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. , 2009, The American journal of medicine.

[510] John A McPherson,et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. , 2009, Journal of the American College of Cardiology.

[511] Jeroen J. Bax,et al. Combined non-invasive anatomical and functional assessment with MSCT and MRI for the detection of significant coronary artery disease in patients with an intermediate pre-test likelihood , 2009, Heart.

[512] G. Matalanis,et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. , 2010, The Journal of thoracic and cardiovascular surgery.

[513] Michael Böhm,et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[514] F. Neumann,et al. Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents. , 2010, American heart journal.

[515] Y. Hayashi,et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). , 2010, JACC. Cardiovascular interventions.

[516] M. Jeong,et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. , 2010, The New England journal of medicine.

[517] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.

[518] Y. Choi,et al. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. , 2010, Journal of the American College of Cardiology.

[519] P. Kirchhof,et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a , 2010, European heart journal.

[520] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[521] P. Post,et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. , 2010, European heart journal.

[522] R. Starling,et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[523] F. Eberli,et al. Drug-eluting versus bare-metal stents in large coronary arteries. , 2010, The New England journal of medicine.

[524] E. Antman,et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis , 2010, The Lancet.

[525] P. Kurlansky,et al. Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. , 2010, The Annals of thoracic surgery.

[526] J. Tu,et al. Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief , 2010, Annals of Internal Medicine.

[527] P. Dorman,et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial , 2010, The Lancet.

[528] K. Kern,et al. Emergent percutaneous coronary intervention for resuscitated victims of out‐of‐hospital cardiac arrest , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[529] D. Mukherjee,et al. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis. , 2010, JACC. Cardiovascular interventions.

[530] P. Armstrong,et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. , 2010, European heart journal.

[531] K. Schulman,et al. Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries , 2010, Circulation.

[532] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[533] A. Kastrati,et al. Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. , 2010, The American journal of cardiology.

[534] J. Vincent,et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. , 2010, JAMA.

[535] K. Harjai,et al. Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study , 2010, PloS one.

[536] A. Baumbach,et al. Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions: The British Bifurcation Coronary Study: Old, New, and Evolving Strategies , 2010, Circulation.

[537] G. Stone,et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2010, JACC. Cardiovascular interventions.

[538] P. Teirstein,et al. Three‐year outcome of drug‐eluting stent implantation for coronary artery bifurcation lesions , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[539] L. Bojö,et al. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[540] Samin K. Sharma,et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.

[541] Seung‐Jung Park,et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. , 2010, Journal of the American College of Cardiology.

[542] Elizabeth R DeLong,et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.

[543] D. Altman,et al. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). , 2010, European heart journal.

[544] F. Carre,et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. , 2010, European heart journal.

[545] C. Macaya,et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[546] Volker Klauss,et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. , 2010, The New England journal of medicine.

[547] P. Armstrong,et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. , 2010, European heart journal.

[548] L. Menicanti,et al. End‐systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy , 2010, European journal of heart failure.

[549] B. Gersh,et al. Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2010, Circulation.

[550] P. Fitzgerald,et al. A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. , 2010 .

[551] D. Delurgio,et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.

[552] J. Afilalo,et al. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. , 2010, American heart journal.

[553] Uwe Siebert,et al. Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .

[554] D. Hoffman,et al. Radial artery conduits improve long-term survival after coronary artery bypass grafting. , 2010, The Annals of thoracic surgery.

[555] A. Kastrati,et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. , 2010, Journal of the American College of Cardiology.

[556] H. Krumholz,et al. Putting ad hoc PCI on pause. , 2010, JAMA.

[557] William Wijns,et al. Experience with revascularization procedures does matter: low volume means worse outcome. , 2010, European heart journal.

[558] A. Iñíguez-Romo,et al. Szabo technique versus conventional angiographic placement in bifurcations 010-001 of Medina and in aorto-ostial stenting: angiographic and procedural results. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[559] C. Acar,et al. Long-term (5- to 20-year) patency of the radial artery for coronary bypass grafting. , 2010, The Journal of thoracic and cardiovascular surgery.

[560] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.

[561] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[562] M. Gnant,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010 .

[563] H. Katus,et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. , 2010, Journal of the American College of Cardiology.

[564] V. Deneer,et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[565] L. Cohn,et al. Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft , 2010, Current opinion in cardiology.

[566] M. Hochadel,et al. Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[567] Volkmar Falk,et al. Guidelines on myocardial revascularization. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[568] Saibal Kar,et al. Polymer-Free Biolimus A9–Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model , 2010, Circulation. Cardiovascular interventions.

[569] I. Koniari,et al. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review , 2010, Journal of cardiothoracic surgery.

[570] Jeroen J. Bax,et al. Prognostic importance of strain and strain rate after acute myocardial infarction. , 2010, European heart journal.

[571] P. Stella,et al. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. , 2010, Journal of the American College of Cardiology.

[572] S. Goergen,et al. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. , 2010, Radiology.

[573] I. Belenkie,et al. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[574] S. Werns. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2010 .

[575] S. Yusuf,et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[576] B. Cortese,et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study , 2010, Heart.

[577] F. Neumann,et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. , 2010, Journal of the American College of Cardiology.

[578] H. Sipilä,et al. Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.

[579] Sunil V. Rao,et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. , 2010, JAMA.

[580] C. Terkelsen,et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[581] J. Spertus,et al. Quantifying the Early Health Status Benefits of Successful Chronic Total Occlusion Recanalization: Results From the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial , 2010, Circulation. Cardiovascular quality and outcomes.

[582] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[583] Michael D Hill,et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.

[584] G. Schuler,et al. Timing of invasive treatment after fibrinolysis in ST elevation myocardial infarction – a meta-analysis of immediate or early routine versus deferred or ischemia-guided randomised controlled trials , 2010, Heart.

[585] A. Kastrati,et al. ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. , 2010, European heart journal.

[586] Ansar Hassan,et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting. , 2010, The Annals of thoracic surgery.

[587] R. Kornowski,et al. The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. , 2010, The Journal of thoracic and cardiovascular surgery.

[588] Jeffrey Gold,et al. Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery: What Happens in Actual Practice? , 2010, Circulation.

[589] Gregg W Stone,et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. , 2010, The New England journal of medicine.

[590] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.

[591] S. de Servi,et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. , 2010, British journal of anaesthesia.

[592] P. Smits,et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial , 2010, The Lancet.

[593] E. Ohman,et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.

[594] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[595] R. Starzyk,et al. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. , 2010, JACC. Cardiovascular interventions.

[596] G. Montalescot,et al. New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis. , 2010, Journal of the American College of Cardiology.

[597] J. Ferrières,et al. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. , 2010, The Journal of clinical endocrinology and metabolism.

[598] V. Pasceri,et al. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. , 2010, Journal of the American College of Cardiology.

[599] A. Ahlsson,et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[600] X. Jouven,et al. Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.

[601] M. Mack,et al. On-pump versus off-pump CABG. , 2010, The New England journal of medicine.

[602] F. Eberli,et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. , 2010, Journal of the American College of Cardiology.

[603] L. Mauri,et al. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). , 2010, The American journal of cardiology.

[604] M. Keltai,et al. Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .

[605] S. Yusuf,et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. , 2010, The New England journal of medicine.

[606] C. Cannon,et al. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis , 2010, Circulation.

[607] J. Rawn,et al. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[608] M. Elayda,et al. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. , 2010, The American journal of cardiology.

[609] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[610] Fredrik Folke,et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[611] M. Mack,et al. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2010, Circulation.

[612] Olaf Franzen,et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention , 2011, Clinical Research in Cardiology.

[613] P. Damman,et al. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. , 2010, Journal of the American College of Cardiology.

[614] C. Don,et al. Carotid revascularization immediately before urgent cardiac surgery practice patterns associated with the choice of carotid artery stenting or endarterectomy: a report from the CARE (Carotid Artery Revascularization and Endarterectomy) registry. , 2011, JACC. Cardiovascular interventions.

[615] P. Serruys,et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. , 2011, JACC. Cardiovascular interventions.

[616] F. Alfonso,et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. , 2010, Journal of the American College of Cardiology.

[617] A. Kastrati,et al. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. , 2011, Circulation.

[618] T. Maruo,et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. , 2011, JACC. Cardiovascular interventions.

[619] M. Sabatier,et al. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. , 2011, The Journal of thoracic and cardiovascular surgery.

[620] M. Mamas,et al. A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis. , 2011, Journal of interventional cardiology.

[621] D. Berman,et al. Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[622] Qinghua Zhou,et al. Inflammatory myofibroblastic tumor invading pulmonary trunk with multiple mediastinal lymph node metastasis. , 2011, The Annals of thoracic surgery.

[623] Dick M. Goedhart,et al. Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial , 2011, Circulation. Cardiovascular interventions.

[624] B. Iung,et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[625] A. Davies,et al. Chapter III: Management of cardiovascular risk factors and medical therapy. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[626] Matti Niemelä,et al. Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study , 2011, Circulation. Cardiovascular interventions.

[627] B. Buxton,et al. The right internal thoracic artery: the forgotten conduit--5,766 patients and 991 angiograms. , 2011, The Annals of thoracic surgery.

[628] A. Moss,et al. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long‐Term Survival in the MADIT‐II Trial , 2011, Journal of cardiovascular electrophysiology.

[629] M. Ranucci,et al. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. , 2011, The Annals of thoracic surgery.

[630] K. Huber,et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial , 2012, Clinical Research in Cardiology.

[631] Gregg W Stone,et al. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. , 2011, Journal of the American College of Cardiology.

[632] D. Dudek,et al. Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.

[633] T. Akasaka,et al. Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. , 2011, Journal of the American College of Cardiology.

[634] S. Silber,et al. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[635] M. Noc,et al. Angiographic characteristics of coronary disease and postresuscitation electrocardiograms in patients with aborted cardiac arrest outside a hospital. , 2011, The American journal of cardiology.

[636] H. Krumholz,et al. National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. , 2011, Archives of internal medicine.

[637] D. Holmes,et al. Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis , 2011 .

[638] A. Bavry,et al. Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. , 2011, Journal of the American College of Cardiology.

[639] G. Lip,et al. RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome , 2011, European heart journal.

[640] V. Chair,et al. ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011 .

[641] L. Neyses,et al. Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .

[642] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[643] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[644] G. Stone,et al. Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. , 2011, The American journal of cardiology.

[645] R. Guyton,et al. Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial. , 2011, The Annals of thoracic surgery.

[646] G. Stone,et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. , 2011, Journal of the American College of Cardiology.

[647] R. Virmani,et al. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. , 2011, Journal of the American College of Cardiology.

[648] G. Stone,et al. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. , 2011, JACC. Cardiovascular interventions.

[649] P. Serruys,et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[650] M. Carrier,et al. Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. , 2011, The Annals of thoracic surgery.

[651] J. Ioannidis,et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes , 2012 .

[652] P. Wenaweser,et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[653] T. Lüscher,et al. Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease , 2011, European heart journal.

[654] Laura Mauri,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[655] M. Leesar,et al. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: A comprehensive meta‐analysis of randomized trials and observational studies comprising 7,994 patients , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[656] Seung‐Jung Park,et al. Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.

[657] Samin K. Sharma,et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. , 2011, Journal of the American College of Cardiology.

[658] M. Jeong,et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. , 2011, The New England journal of medicine.

[659] A. Kastrati,et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial , 2011, The Lancet.

[660] Saibal Kar,et al. Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.

[661] Li-jun Guo,et al. The relationship between kidney function and angiographically-derived SYNTAX score. , 2011, The Canadian journal of cardiology.

[662] M. Bown,et al. Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[663] T. Fuchs,et al. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[664] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.

[665] H. Schuchlenz,et al. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. , 2011, European heart journal.

[666] T. Henry,et al. Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment–Elevation Myocardial Infarction , 2011, Circulation.

[667] Seung‐Jung Park,et al. Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease , 2011, Circulation.

[668] B. Gersh,et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.

[669] B. Gersh,et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial , 2011, The Lancet.

[670] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.

[671] M. Valgimigli,et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury , 2011, Circulation.

[672] A. Jacobs,et al. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). , 2011, The American journal of cardiology.

[673] M. Leoncini,et al. Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary Angioplasty: A Randomized, Controlled Trial , 2011, Circulation. Cardiovascular interventions.

[674] T. Henry,et al. Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase , 2011, Circulation.

[675] K. Anstrom,et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. , 2011, Journal of the American College of Cardiology.

[676] R. de Caterina,et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. , 2011, European heart journal.

[677] B. Rangan,et al. Use of drug‐eluting stents for chronic total occlusions: A systematic review and meta‐analysis , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[678] C. Bhamidipati,et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. , 2011, The Journal of thoracic and cardiovascular surgery.

[679] M. Mamas,et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. , 2011, European heart journal.

[680] E. Blackstone,et al. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. , 2011, JAMA.

[681] D. Atar,et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.

[682] Guido Germano,et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. , 2011, European heart journal.

[683] Li-sheng Liu,et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. , 2011, European heart journal.

[684] Deepak L. Bhatt,et al. Apixaban with antiplatelet therapy after acute coronary syndrome. , 2011, The New England journal of medicine.

[685] N. Schork,et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.

[686] A. Colombo,et al. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. , 2011, The American journal of cardiology.

[687] P. Serruys,et al. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[688] Sunil V. Rao,et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[689] M. Niemelä,et al. Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III , 2011, Circulation.

[690] Daniel Polsky,et al. Coronary revascularization trends in the United States, 2001-2008. , 2011, JAMA.

[691] M. Zenati,et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. , 2011, The Journal of thoracic and cardiovascular surgery.

[692] F. Van de Werf,et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. , 2011, European heart journal.

[693] A. Dunning,et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. , 2011, Journal of the American College of Cardiology.

[694] Betti Giusti,et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. , 2011, JAMA.

[695] M. Misfeld,et al. Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8 studies. , 2011, The Journal of thoracic and cardiovascular surgery.

[696] H. Ulmer,et al. Second Internal Thoracic Artery Versus Radial Artery in Coronary Artery Bypass Grafting: A Long-Term, Propensity Score–Matched Follow-Up Study , 2011, Circulation.

[697] Mouaz Al-Mallah,et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without know , 2011, Journal of the American College of Cardiology.

[698] J. Tu,et al. Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study. , 2011, JACC. Cardiovascular interventions.

[699] W. Ghali,et al. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. , 2011, The Annals of thoracic surgery.

[700] G. Schuler,et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. , 2011, Journal of the American College of Cardiology.

[701] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[702] L. Husmann,et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. , 2011, European Heart Journal.

[703] Jun-Jie Zhang,et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. , 2011, Journal of the American College of Cardiology.

[704] C. Lory,et al. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation , 2011, Critical care.

[705] J. D. de Lemos,et al. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. , 2011, JACC. Cardiovascular interventions.

[706] F. Eberli,et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial , 2011, The Lancet.

[707] J. Birkmeyer,et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. , 2011, JAMA.

[708] J. Jokinen,et al. Clinical value of intra-operative transit-time flow measurement for coronary artery bypass grafting: a prospective angiography-controlled study. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[709] R. Hetzer,et al. Late wound healing problems after use of BioGlue for apical hemostasis during transapical aortic valve implantation. , 2011, Interactive cardiovascular and thoracic surgery.

[710] M. Mack,et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. , 2011, The Journal of thoracic and cardiovascular surgery.

[711] M. Valgimigli. PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY , 2011 .

[712] M. Jeong,et al. Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry , 2011, Heart.

[713] Deepak L. Bhatt,et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary , 2011, Circulation. Cardiovascular interventions.

[714] R. Damiano,et al. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. , 2011, The Journal of thoracic and cardiovascular surgery.

[715] G. Stone,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. , 2011, Journal of the American College of Cardiology.

[716] P. Serruys,et al. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[717] G. Stone,et al. SYNTAX Score Reproducibility and Variability Between Interventional Cardiologists, Core Laboratory Technicians, and Quantitative Coronary Measurements , 2011, Circulation. Cardiovascular interventions.

[718] Benjamin Sohmer,et al. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[719] M. Zembala,et al. Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in MultI-vessel coronary artery DisEaSe (POLMIDES) - study design. , 2011, Kardiologia polska.

[720] Jörg Hausleiter,et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.

[721] G. Stone,et al. Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. , 2011, The American journal of cardiology.

[722] Á. Avezum,et al. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. , 2011, The American journal of cardiology.

[723] C. O'connor,et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.

[724] H. Krumholz,et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. , 2011, JAMA.

[725] D. Taggart,et al. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[726] Act Investigators. Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.

[727] B. Seifert,et al. Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting. , 2011, The Journal of thoracic and cardiovascular surgery.

[728] J. Smith,et al. Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2011, European heart journal.

[729] G. Richardt,et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. , 2012, The American journal of cardiology.

[730] J. W. Louwerenburg,et al. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. , 2012, Journal of the American College of Cardiology.

[731] E. Romagnoli,et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. , 2012, Journal of the American College of Cardiology.

[732] Michael J Pencina,et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. , 2012, JAMA.

[733] L. Bonati,et al. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. , 2012, The Cochrane database of systematic reviews.

[734] P. Serruys,et al. Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort Study , 2012, Circulation.

[735] F. Veglia,et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. , 2012, JACC. Cardiovascular interventions.

[736] G. Schuler,et al. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). , 2012, European heart journal.

[737] B. Dai,et al. Efficacy of Short-Term High-Dose Statin in Preventing Contrast-Induced Nephropathy: A Meta-Analysis of Seven Randomized Controlled Trials , 2012, PloS one.

[738] David L. Brown,et al. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. , 2012, Archives of internal medicine.

[739] Scott N. Hwang,et al. Avoiding the clamp during off-pump coronary artery bypass reduces cerebral embolic events: results of a prospective randomized trial. , 2012, Interactive cardiovascular and thoracic surgery.

[740] R. Blankstein,et al. Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.

[741] G. Lip,et al. Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score ? , 2012 .

[742] Giuseppe Ambrosio,et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[743] M. Jeong,et al. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study , 2012, Circulation.

[744] D. Hoffman,et al. Coronary Artery Bypass Grafting Using the Radial Artery: Clinical Outcomes, Patency, and Need for Reintervention , 2012, Circulation.

[745] Sudeshna Banerjee,et al. Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. , 2012, The American journal of cardiology.

[746] F. Biancari,et al. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. , 2012, The Annals of thoracic surgery.

[747] P. Stella,et al. A multicenter randomized comparison of drug‐eluting balloon plus bare‐metal stent versus bare‐metal stent versus drug‐eluting stent in bifurcation lesions treated with a single‐stenting technique: Six‐month angiographic and 12‐month clinical results of the drug‐eluting balloon in bifurcations trial , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[748] K. Hauptmann,et al. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. , 2012, Journal of the American College of Cardiology.

[749] Edward O'Brien,et al. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial , 2012, The Lancet.

[750] A. Kirtane,et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials , 2012, BMJ : British Medical Journal.

[751] P. Serruys,et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. , 2012, JACC. Cardiovascular imaging.

[752] J. Andreasen,et al. Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[753] P. Serruys,et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. , 2012, European heart journal.

[754] T. Vassiliades,et al. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. , 2012, The Annals of thoracic surgery.

[755] M. Bertolet,et al. Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) , 2012, Circulation. Cardiovascular interventions.

[756] S. Yusuf,et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. , 2012, The New England journal of medicine.

[757] Craig R. Smith,et al. Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network. , 2012, The Journal of thoracic and cardiovascular surgery.

[758] Howard K. Song,et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.

[759] D. Foley,et al. Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial. , 2012, Journal of the American College of Cardiology.

[760] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.

[761] K. Werdan,et al. Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence. , 2012, Artificial organs.

[762] D. Berman,et al. All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) , 2012, European heart journal.

[763] Jeong Hoon Yang,et al. Randomized comparison of conservative versus aggressive strategy for provisional side branch intervention in coronary bifurcation lesions: results from the SMART-STRATEGY (Smart Angioplasty Research Team-Optimal Strategy for Side Branch Intervention in Coronary Bifurcation Lesions) randomized trial. , 2012, JACC. Cardiovascular interventions.

[764] S. Bangalore,et al. Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2012, Circulation. Cardiovascular interventions.

[765] M. Pfisterer,et al. Coronary artery disease progression late after successful stent implantation. , 2012, Journal of the American College of Cardiology.

[766] M. Sabatine,et al. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2012, Journal of the American College of Cardiology.

[767] F. Dagenais,et al. Completeness of revascularization and survival among octogenarians with triple-vessel disease. , 2012, The Annals of thoracic surgery.

[768] Y. Jang,et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). , 2012, Journal of the American College of Cardiology.

[769] Peter K. Smith,et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. , 2012, Journal of the American College of Cardiology.

[770] P. Teirstein,et al. Left main percutaneous coronary intervention. , 2012, Journal of the American College of Cardiology.

[771] Nikola Jagic,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[772] Nishant R. Shah,et al. Percutaneous Circulatory Support in Cardiogenic Shock: Interventional Bridge to Recovery , 2012, Circulation.

[773] J. Brachmann,et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. , 2012, Journal of the American College of Cardiology.

[774] M. Allessie,et al. Post-operative atrial fibrillation: a maze of mechanisms , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[775] Samin K. Sharma,et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. , 2012, Journal of the American College of Cardiology.

[776] B. Gersh,et al. Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2012, Circulation.

[777] G. Stone,et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. , 2012, JAMA.

[778] H. Jneid,et al. Clinical Outcomes of Percutaneous Interventions in Saphenous Vein Grafts Using Drug‐Eluting Stents Compared to Bare‐Metal Stents: A Comprehensive Meta‐Analysisof All Randomized Clinical Trials , 2012, Clinical cardiology.

[779] J. Fajadet,et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. , 2012, Journal of the American College of Cardiology.

[780] N. Bruining,et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures , 2012, European heart journal.

[781] J. Messenger,et al. Off-Pump Coronary Artery Bypass Surgery Is Associated With Worse Arterial and Saphenous Vein Graft Patency and Less Effective Revascularization: Results From the Veterans Affairs Randomized On/Off Bypass (ROOBY) Trial , 2012, Circulation.

[782] J. Fleg,et al. Coronary CT angiography versus standard evaluation in acute chest pain. , 2012, The New England journal of medicine.

[783] H. Schaff,et al. Multiple Arterial Grafts Improve Late Survival of Patients Undergoing Coronary Artery Bypass Graft Surgery: Analysis of 8622 Patients With Multivessel Disease , 2012, Circulation.

[784] M. Böhm,et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2012, JACC. Cardiovascular interventions.

[785] E. Yow,et al. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. , 2012, The Annals of thoracic surgery.

[786] K. Park,et al. RELATIONSHIP BETWEEN FRACTIONAL FLOW RESERVE AND ANGIOGRAPHIC AND INTRAVASCULAR ULTRASOUND PARAMETERS IN OSTIAL LESIONS: MAJOR EPICARDIAL VESSEL VS. SIDE BRANCH OSTIAL LESIONS , 2012 .

[787] D. Dvir,et al. Drug eluting stenting in bifurcation coronary lesions long‐term results applying a systematic treatment strategy , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[788] A. Seth,et al. A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients. , 2012, Indian heart journal.

[789] J. Harnek,et al. Comparison of two drug-eluting balloons: a report from the SCAAR registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[790] R. Hetzer,et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. , 2012, Interactive cardiovascular and thoracic surgery.

[791] G. Wright,et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. , 2012, Journal of the American College of Cardiology.

[792] P. Smits,et al. Objectives Background Methods Results Conclusions , 2022 .

[793] P. Stella,et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-mont , 2012, Journal of the American College of Cardiology.

[794] Rolf H H Groenwold,et al. Performance of the original EuroSCORE. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[795] J. Afilalo,et al. Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. , 2012, European heart journal.

[796] A. Laupacis,et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). , 2012, Journal of the American College of Cardiology.

[797] P. Serruys,et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[798] Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis , 2012, BMC Research Notes.

[799] Akiko Maehara,et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.

[800] G. Stone,et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placem , 2012, Journal of the American College of Cardiology.

[801] R. Habib,et al. Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients. , 2012, The Annals of thoracic surgery.

[802] G. Ferrari,et al. Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: validation of a contemporary surgical experience. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[803] M. Price,et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. , 2012, JAMA.

[804] Krzysztof Wróbel,et al. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial , 2012, Circulation.

[805] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[806] Takeshi Kimura,et al. Benefits of Off-Pump Coronary Artery Bypass Grafting in High-Risk Patients , 2012, Circulation.

[807] L. Klassen,et al. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. , 2012, The Annals of thoracic surgery.

[808] M. Mack,et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[809] P. Kurlansky,et al. Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up. , 2012, The Journal of thoracic and cardiovascular surgery.

[810] K. Park,et al. Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: major epicardial vessel versus side branch ostial lesions. , 2012, JACC. Cardiovascular interventions.

[811] W. Winkelmayer,et al. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[812] Giuseppe Biondi-Zoccai,et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[813] G. Schuler,et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial , 2012, The Lancet.

[814] A. Kastrati,et al. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial]. , 2012, Vestnik rentgenologii i radiologii.

[815] G. Friedrich,et al. Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results. , 2012, The Annals of thoracic surgery.

[816] A. Colombo,et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. , 2012, Journal of the American College of Cardiology.

[817] L. Chawla,et al. Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. , 2012, Journal of the American Society of Nephrology : JASN.

[818] C. Reid,et al. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. , 2012, The American journal of cardiology.

[819] P. Serruys,et al. Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[820] Paul Burton,et al. Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[821] Craig I. Coleman,et al. Diagnostic Accuracy of Cardiac Positron Emission Tomography Versus Single Photon Emission Computed Tomography for Coronary Artery Disease: A Bivariate Meta-Analysis , 2012, Circulation. Cardiovascular imaging.

[822] B. Linden. On-pump vs off-pump CABG , 2012 .

[823] E. Braunwald,et al. A tale of coronary artery disease and myocardial infarction. , 2012, The New England journal of medicine.

[824] C. Ronco,et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2012, The American journal of medicine.

[825] G. Stone,et al. Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. , 2012, Journal of the American College of Cardiology.

[826] L. Køber,et al. Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study , 2012, Circulation.

[827] S. Bailey,et al. A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[828] Marco Valgimigli,et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. , 2012, European heart journal.

[829] Sean M. O'Brien,et al. Comparative effectiveness of revascularization strategies. , 2012, The New England journal of medicine.

[830] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.

[831] Mårten Rosenqvist,et al. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.

[832] Samin K. Sharma,et al. Comparative Outcomes for Patients Who Do and Do Not Undergo Percutaneous Coronary Intervention for Stable Coronary Artery Disease in New York , 2012, Circulation.

[833] G. Montalescot,et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. , 2012, JAMA.

[834] Marissa Miller,et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.

[835] C. Held,et al. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. , 2012, Journal of the American College of Cardiology.

[836] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[837] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[838] M. Morice,et al. Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[839] P. Rehak,et al. Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) Study , 2012, Circulation. Cardiovascular interventions.

[840] J. Kelder,et al. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[841] E. Vicaut,et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[842] M. Valgimigli,et al. Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. , 2012, American heart journal.

[843] D. Taggart. Incomplete revascularization: appropriate and inappropriate. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[844] K. Kern. Optimal treatment of patients surviving out-of-hospital cardiac arrest. , 2012, JACC. Cardiovascular interventions.

[845] M. D. de Sousa,et al. Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials , 2012, Systematic Reviews.

[846] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[847] R. Tölg,et al. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[848] A. Hughes,et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. , 2012, Journal of the American College of Cardiology.

[849] M. Mack,et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. , 2012, JACC. Cardiovascular interventions.

[850] A. Bryan,et al. How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23 740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database , 2012, Heart.

[851] G. Schuler,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[852] Ajay K. Jain,et al. Successful recanalization of chronic total occlusions is associated with improved long-term survival. , 2012, JACC. Cardiovascular interventions.

[853] G. Stone,et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis , 2012, The Lancet.

[854] G. Stukenborg,et al. The effect of surgeon volume on mortality for off-pump coronary artery bypass grafting. , 2012, The Journal of thoracic and cardiovascular surgery.

[855] Sean M. O'Brien,et al. Predictors of Long-Term Survival After Coronary Artery Bypass Grafting Surgery: Results From the Society of Thoracic Surgeons Adult Cardiac Surgery Database (The ASCERT Study) , 2012, Circulation.

[856] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[857] M. Lemma,et al. On-pump versus off-pump coronary artery bypass surgery in high-risk patients: operative results of a prospective randomized trial (on-off study). , 2012, The Journal of thoracic and cardiovascular surgery.

[858] Robert L Kormos,et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[859] Sean M. O'Brien,et al. Prediction of Long-Term Mortality After Percutaneous Coronary Intervention in Older Adults: Results From the National Cardiovascular Data Registry , 2012, Circulation.

[860] H. Luckraz,et al. Heart team discussion in managing patients with coronary artery disease: outcome and reproducibility. , 2012, Interactive cardiovascular and thoracic surgery.

[861] M. Carrier,et al. Management of early postoperative coronary artery bypass graft failure. , 2012, Interactive cardiovascular and thoracic surgery.

[862] Seung‐Jung Park,et al. Comparative long‐term efficacy and safety of drug‐eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[863] K. Anstrom,et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. , 2012, JACC. Cardiovascular interventions.

[864] J. Marchesini,et al. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial , 2012, Circulation.

[865] Joris A H de Groot,et al. Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions , 2012, Heart.

[866] C. Schindler,et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. , 2012, European heart journal.

[867] C. Reid,et al. Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). , 2012, The American journal of cardiology.

[868] Susanne Nørgaard Madsen,et al. On-Pump Versus Off-Pump Coronary Artery Bypass Surgery in Elderly Patients: Results From the Danish On-Pump Versus Off-Pump Randomization Study , 2012, Circulation.

[869] G. Wells,et al. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. , 2012, Journal of the American College of Cardiology.

[870] Deepak L. Bhatt,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. , 2012, The New England journal of medicine.

[871] J. Pepper,et al. Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial , 2012, Circulation.

[872] C. Herzog,et al. Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease , 2012, Circulation.

[873] Fernando Alfonso,et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis , 2012, Heart.

[874] A. Kastrati,et al. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. , 2012, European heart journal.

[875] J. Spertus,et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. , 2012, JACC. Cardiovascular interventions.

[876] Sean M. O'Brien,et al. Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. , 2012, JAMA.

[877] I. Mrdović,et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial , 2012, Coronary artery disease.

[878] Raimund Erbel,et al. [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[879] M. Böhm,et al. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[880] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .

[881] Regina M. Hardison,et al. Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial , 2012, Circulation.

[882] S. James,et al. Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts. , 2012, American heart journal.

[883] J. Fraser,et al. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. , 2012, The Annals of thoracic surgery.

[884] E. Vicaut,et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. , 2012, The New England journal of medicine.

[885] M. Pasque,et al. Radial Artery Free and T Graft Patency as Coronary Artery Bypass Conduit Over a 15-Year Period , 2012, Circulation.

[886] Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials , 2012, Circulation.

[887] G. Stone,et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. , 2012, Archives of internal medicine.

[888] Akshay S. Desai,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[889] Joel Huber,et al. Weighting composite endpoints in clinical trials: essential evidence for the heart team. , 2012, The Annals of thoracic surgery.

[890] E. Steyerberg,et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. , 2012, European heart journal.

[891] T. Mesana,et al. Is Bilateral Internal Thoracic Artery Use Safe in the Elderly? , 2012, Journal of cardiac surgery.

[892] Jun-Jie Zhang,et al. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[893] P. Kurlansky,et al. Bilateral Internal Mammary Artery Grafting Enhances Survival in Diabetic Patients: A 30-Year Follow-Up of Propensity Score–Matched Cohorts , 2012, Circulation.

[894] J. Gummert,et al. Clampless Off-Pump Versus Conventional Coronary Artery Revascularization: A Propensity Score Analysis of 788 Patients , 2012, Circulation.

[895] Samer A M Nashef,et al. EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[896] D. Berman,et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. , 2012, American heart journal.

[897] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[898] C. Zhang,et al. Meta‐analysis of amiodarone versus beta‐blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery , 2012, Internal medicine journal.

[899] P. Serruys,et al. Seven‐year safety and efficacy of the unrestricted use of drug‐eluting stents in saphenous vein bypass grafts , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[900] J. Gillard,et al. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. , 2013, Journal of the American College of Cardiology.

[901] F. Neumann,et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. , 2013, JACC. Cardiovascular interventions.

[902] Deepak L. Bhatt,et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. , 2013, JAMA.

[903] P. Erwin,et al. Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. , 2013, The Annals of thoracic surgery.

[904] P. Serruys,et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials , 2013, The Lancet.

[905] V. Fuster,et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials. , 2013, Journal of the American College of Cardiology.

[906] Michael Joner,et al. Tissue Characterization After Drug-Eluting Stent Implantation Using Optical Coherence Tomography , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[907] B. Lytle,et al. Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation. , 2013, Journal of the American College of Cardiology.

[908] V. Falk,et al. Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. , 2013, European heart journal.

[909] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[910] A. Akar,et al. Comparison of original EuroSCORE, EuroSCORE II and STS risk models in a Turkish cardiac surgical cohort. , 2013, Interactive cardiovascular and thoracic surgery.

[911] P. Damman,et al. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure , 2013, Journal of cardiovascular medicine.

[912] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[913] Fumiaki Ikeno,et al. Fractional Flow Reserve Assessment of Left Main Stenosis in the Presence of Downstream Coronary Stenoses , 2012, Circulation. Cardiovascular interventions.

[914] M. Lubberink,et al. Hybrid Imaging Using Quantitative H215O PET and CT-Based Coronary Angiography for the Detection of Coronary Artery Disease , 2013, The Journal of Nuclear Medicine.

[915] H. Jneid,et al. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. , 2013, International journal of cardiology.

[916] S. Takanashi,et al. Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris. , 2013, The Journal of thoracic and cardiovascular surgery.

[917] G. Dangas,et al. Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study. , 2013, Journal of the American College of Cardiology.

[918] D. Mukherjee,et al. Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta‐analysis , 2013, Pacing and clinical electrophysiology : PACE.

[919] Deepak L. Bhatt,et al. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. , 2013, Journal of the American College of Cardiology.

[920] C. V. van Mieghem,et al. Fractional Flow Reserve–Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2013, Circulation.

[921] G. Schuler,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[922] H. Miyata,et al. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[923] Mario Fusaro,et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.

[924] Yeong-Hoon Choi,et al. Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. , 2013, The Journal of surgical research.

[925] V. Falk,et al. Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects. , 2013, European heart journal.

[926] M. Bots,et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up? , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[927] J. Tatoulis. Total arterial coronary revascularization-patient selection, stenoses, conduits, targets. , 2013, Annals of cardiothoracic surgery.

[928] G. Knapp,et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials , 2013, Heart.

[929] E. Hannan,et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. , 2013, The Annals of thoracic surgery.

[930] P. Serruys,et al. New concepts in the design of drug-eluting coronary stents , 2013, Nature Reviews Cardiology.

[931] T. Akasaka,et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. , 2013, Journal of the American College of Cardiology.

[932] K. Swedberg,et al. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. , 2013, European heart journal.

[933] H. Suryapranata,et al. A meta-analytic overview of thrombectomy during primary angioplasty. , 2013, International journal of cardiology.

[934] A. Kastrati,et al. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. , 2013, Journal of the American College of Cardiology.

[935] Deepak L. Bhatt,et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.

[936] P. Bagos,et al. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease , 2013, Circulation.

[937] S. Garcia,et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. , 2013, Journal of the American College of Cardiology.

[938] J. Stehli,et al. Registry for the Evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT). , 2013, European heart journal cardiovascular Imaging.

[939] B. Fabri,et al. Comparison of the EuroSCORE II and Society of Thoracic Surgeons 2008 risk tools. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[940] D. Reda,et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. , 2013, Journal of the American College of Cardiology.

[941] A. Pereira,et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. , 2013, American heart journal.

[942] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[943] Amir Lerman,et al. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. , 2013, European heart journal.

[944] L. Räber,et al. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[945] P. Bannon,et al. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. , 2013, The Journal of thoracic and cardiovascular surgery.

[946] J. Rouleau,et al. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. , 2013, The Journal of thoracic and cardiovascular surgery.

[947] B. Gersh,et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? , 2013, The Lancet.

[948] W. Boden,et al. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris. , 2013, The Canadian journal of cardiology.

[949] Farooq,et al. Revascularization strategies in patients with diabetes. , 2013 .

[950] A. Parkhomenko,et al. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). , 2013, Journal of the American College of Cardiology.

[951] F. Grover,et al. Repeat Coronary Revascularization After Coronary Artery Bypass Surgery in Older Adults: The Society of Thoracic Surgeons’ National Experience, 1991–2007 , 2013, Circulation.

[952] S. Sasaki,et al. Presentations of acute coronary syndrome related to coronary lesion morphologies as assessed by intravascular ultrasound and optical coherence tomography. , 2013, International journal of cardiology.

[953] R. Whitbourn,et al. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. , 2013, JACC. Cardiovascular interventions.

[954] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.

[955] L. Fauchier,et al. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation , 2013, Thrombosis and Haemostasis.

[956] D. Berman,et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. , 2013, Journal of the American College of Cardiology.

[957] J. Schwitter,et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.

[958] Á. Ferraz,et al. Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: meta-analysis and meta-regression of 4817 patients. , 2013, Interactive cardiovascular and thoracic surgery.

[959] Michael Joner,et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. , 2013, JACC. Cardiovascular interventions.

[960] B. Lytle,et al. Endoscopic radial artery harvesting procedure for coronary artery bypass grafting. , 2013, Annals of cardiothoracic surgery.

[961] V. Fuster,et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. , 2013, The lancet. Diabetes & endocrinology.

[962] S. Yusuf,et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. , 2013, The New England journal of medicine.

[963] E. Vicaut,et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. , 2013, The New England journal of medicine.

[964] M. Mamas,et al. Influence of access site choice on incidence of neurologic complications after percutaneous coronary intervention. , 2013, American heart journal.

[965] S. Yusuf,et al. Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial , 2013, Circulation.

[966] M. Poullis,et al. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[967] Klaus Fuglsang Kofoed,et al. Cardiac computed tomography guided treatment strategy in patients with recent acute-onset chest pain: results from the randomised, controlled trial: CArdiac cT in the treatment of acute CHest pain (CATCH). , 2013, International journal of cardiology.

[968] B. Gersh,et al. ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[969] C. Berry,et al. Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[970] S. Pocock,et al. Bivalirudin started during emergency transport for primary PCI. , 2013, The New England journal of medicine.

[971] R. Virmani,et al. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[972] E. Tuzcu,et al. Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. , 2013, Journal of the American College of Cardiology.

[973] Ajay K. Jain,et al. Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. , 2013, European heart journal.

[974] D. Taggart,et al. A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting. , 2013, Annals of cardiothoracic surgery.

[975] J. Lock,et al. Transcatheter Closure of Post-myocardial Infarction Ventricular Septal Rupture , 2013, Circulation. Cardiovascular interventions.

[976] Gregg W Stone,et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. , 2013, The New England journal of medicine.

[977] Peter L Duffy,et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study , 2013 .

[978] S. Girotra,et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. , 2013, JACC. Cardiovascular interventions.

[979] Sharon-Lise T Normand,et al. Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease , 2013, Circulation.

[980] S. Maes,et al. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[981] M. Cerqueira,et al. Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction: Inducible Ischemia Versus Hibernating Myocardium , 2013, Circulation. Cardiovascular imaging.

[982] L. Kuramoto,et al. The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: a population-based observational study , 2013, Journal of Cardiothoracic Surgery.

[983] S. Kaul,et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. , 2013, European heart journal.

[984] H. Ulmer,et al. Simple adaptations of surgical technique to critically reduce the risk of postoperative sternal complications in patients receiving bilateral internal thoracic arteries. , 2013, Interactive cardiovascular and thoracic surgery.

[985] M. Hawn,et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. , 2013, JAMA.

[986] Dolores Corella,et al. Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[987] A. Kastrati,et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.

[988] F. Neumann,et al. Role of euroSCORE II in predicting long-term outcome after percutaneous catheter intervention for coronary triple vessel disease or left main stenosis. , 2013, International journal of cardiology.

[989] H. Wijeysundera,et al. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. , 2013, JAMA.

[990] A. Gitt,et al. NEWLY DIAGNOSED DIABETES AND PREDIABETES IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION PREDICTS ADVERSE OUTCOMES DURING A THREE-YEAR FOLLOW-UP: RESULTS OF THE SWEETHEART REGISTRY , 2013 .

[991] F. Bakaeen. Endoscopic vein harvest for coronary artery bypass grafting is safe. , 2013, The Journal of surgical research.

[992] P. Serruys,et al. CT-SYNTAX score: a feasibility and reproducibility Study. , 2013, JACC. Cardiovascular imaging.

[993] Samin K. Sharma,et al. Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.

[994] A. Jacobs,et al. Time to treatment in patients with STEMI. , 2013, The New England journal of medicine.

[995] M. Movahed,et al. Prevention of Post–Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation: Efficacy of Prophylactic Beta‐Blockers in the Modern Era , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[996] R. Schnabel,et al. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. , 2013, International journal of cardiology.

[997] G. Lip,et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. , 2013, European heart journal.

[998] Michail I. Papafaklis,et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. , 2013, Journal of the American College of Cardiology.

[999] G. Schuler,et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial. , 2013, JACC. Cardiovascular interventions.

[1000] R. Guyton,et al. Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index. , 2013, The Journal of thoracic and cardiovascular surgery.

[1001] Soonchang Hong,et al. Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting. , 2013, The Journal of surgical research.

[1002] R. Habib,et al. Late effects of radial artery vs saphenous vein grafting for multivessel coronary bypass surgery in diabetics: a propensity-matched analysis. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1003] V. Fuster,et al. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. , 2013, JAMA.

[1004] M. Shishehbor,et al. Strategies for multivessel revascularization in patients with diabetes , 2013 .

[1005] R. de Caterina,et al. The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. , 2013, International journal of cardiology.

[1006] G. Stone,et al. Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.

[1007] V. Lorenzoni,et al. Detection of Obstructive Coronary Artery Disease by Non Invasive Anatomical and Functional Imaging. Results of the Multicenter European EVINCI Study , 2013 .

[1008] Hyung-Bok Park,et al. Noninvasive Fractional Flow Reserve Derived From Computed Tomography Angiography for Coronary Lesions of Intermediate Stenosis Severity: Results From the DeFACTO Study , 2013, Circulation. Cardiovascular imaging.

[1009] G. Stone,et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. , 2013, Journal of the American College of Cardiology.

[1010] J. Zamorano,et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.

[1011] A. Íñiguez,et al. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.

[1012] B. Uretsky,et al. Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data , 2013, Journal of the American Heart Association.

[1013] D. Berman,et al. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. , 2013, European heart journal.

[1014] L. Køber,et al. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. , 2013, Journal of the American College of Cardiology.

[1015] Christian Pristipino,et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1016] Raimund Erbel,et al. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial , 2013, The Lancet.

[1017] Peter L Duffy,et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.

[1018] J. Messenger,et al. Clinical ResearchInterventional CardiologyThe Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis From the National Cardiovascular Data Registry (2007 to 2011) , 2013 .

[1019] P. Erwin,et al. Dual Anti‐platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta‐Analysis , 2013, Journal of cardiac surgery.

[1020] B. Kemkes,et al. Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement , 2014, General Thoracic and Cardiovascular Surgery.

[1021] Y. Hayashi,et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. , 2013, American heart journal.

[1022] M. Niemelä,et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. , 2013, Journal of the American College of Cardiology.

[1023] M. Pencina,et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. , 2013, Journal of the American College of Cardiology.

[1024] Antonio Colombo,et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.

[1025] M. Shishehbor,et al. A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. , 2013, Journal of the American College of Cardiology.

[1026] S. Hahn,et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. , 2013, American heart journal.

[1027] Tom Adriaenssens,et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[1028] Robert L Kormos,et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[1029] M. Joner,et al. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1030] R. Whitbourn,et al. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1031] R. Torguson,et al. Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1032] D. Holmes,et al. Drug-eluting coronary-artery stents. , 2013, The New England journal of medicine.

[1033] D. Berman,et al. Usefulness of coronary computed tomography angiography to predict mortality and myocardial infarction among Caucasian, African and East Asian ethnicities (from the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter] Registry). , 2013, The American journal of cardiology.

[1034] M. Mack,et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1035] F. Mohr,et al. Impact of Expeditious Management of Perioperative Myocardial Ischemia in Patients Undergoing Isolated Coronary Artery Bypass Surgery , 2013, Circulation.

[1036] Y. Liu,et al. Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1037] P. Serruys,et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. , 2013, JACC. Cardiovascular interventions.

[1038] B. Medalion,et al. Long-term outcomes of patients with diabetes receiving bilateral internal thoracic artery grafts. , 2013, The Journal of thoracic and cardiovascular surgery.

[1039] L. M. Maroto Castellanos,et al. Validation of EuroSCORE II on a single-centre 3800 patient cohort. , 2013, Interactive cardiovascular and thoracic surgery.

[1040] Ri-tai Huang,et al. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1041] T. Mihaljevic,et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. , 2013, Journal of the American College of Cardiology.

[1042] Onur Şen,et al. Comparison of conventional and no-touch techniques in harvesting saphenous vein for coronary artery bypass grafting in view of endothelial damage. , 2013, The heart surgery forum.

[1043] M. Togni,et al. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial , 2013, The Lancet.

[1044] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.

[1045] R. Whitbourn,et al. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). , 2013, JACC. Cardiovascular interventions.

[1046] Antonio Colombo,et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II , 2013, The Lancet.

[1047] E. Hess,et al. Triple rule-out computed tomographic angiography for chest pain: a diagnostic systematic review and meta-analysis. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[1048] Neville Kukreja,et al. Use of thrombectomy devices in primary percutaneous coronary intervention: a systematic review and meta-analysis. , 2013, International journal of cardiology.

[1049] E. Vicaut,et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). , 2013, The American journal of cardiology.

[1050] Shengshou Hu,et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. , 2013, Journal of the American College of Cardiology.

[1051] B. Lytle. Bilateral internal thoracic artery grafting. , 2013, Annals of cardiothoracic surgery.

[1052] A. Diegeler,et al. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. , 2013, The New England journal of medicine.

[1053] Deepak L. Bhatt,et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data , 2013, The Lancet.

[1054] C. Terkelsen,et al. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial , 2013, The Lancet.

[1055] Iain Buchan,et al. Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1056] E. Omerovic,et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. , 2014, The New England journal of medicine.

[1057] Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis , 2014, BMJ : British Medical Journal.

[1058] Hyun-Jae Kang,et al. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. , 2014, European heart journal.

[1059] V. Fuster,et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. , 2014, Journal of the American College of Cardiology.

[1060] J. Birkmeyer,et al. Understanding the volume-outcome effect in cardiovascular surgery: the role of failure to rescue. , 2014, JAMA surgery.

[1061] Gary S. Mintz,et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study , 2014, Circulation.

[1062] P. Wenaweser,et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. , 2014, European heart journal.

[1063] J. Healey,et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. , 2014, JAMA.

[1064] A. Íñiguez,et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). , 2014, Journal of the American College of Cardiology.

[1065] D. Altman,et al. Effect of Bilateral Internal Mammary Artery Grafts on Long-Term Survival: A Meta-Analysis Approach , 2014, Circulation.

[1066] M. Mack,et al. Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial , 2014, Circulation.

[1067] K. Huber,et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention , 2013, European heart journal.

[1068] C. Hamm,et al. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. , 2014, Journal of the American College of Cardiology.

[1069] C. Cannon,et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial , 2014, European heart journal.

[1070] Mike Fisher,et al. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial , 2014, The Lancet.

[1071] G. Montalescot,et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. , 2014, The New England journal of medicine.

[1072] S. Windecker,et al. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1073] S. Villani,et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). , 2014, Journal of the American College of Cardiology.

[1074] Samin K. Sharma,et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. , 2014, Journal of the American College of Cardiology.

[1075] Seung‐Jung Park,et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis. , 2014, JACC. Cardiovascular interventions.

[1076] S. Silber,et al. Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. , 2014, European heart journal.

[1077] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[1078] M. Akay,et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. , 2014, JAMA internal medicine.

[1079] L. Velicki,et al. Clinical Performance of the EuroSCORE II Compared with the Previous EuroSCORE Iterations , 2014, Thoracic and Cardiovascular Surgeon.

[1080] Elias Sanidas,et al. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. , 2014, JACC. Cardiovascular interventions.

[1081] G. Schuler,et al. Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial. , 2014, Journal of the American College of Cardiology.

[1082] M. Mack,et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. , 2014, European heart journal.

[1083] P. Myles. Meaningful outcome measures in cardiac surgery. , 2014, The journal of extra-corporeal technology.

[1084] R. D. de Winter,et al. Standardizing definitions for hybrid coronary revascularization. , 2014, The Journal of thoracic and cardiovascular surgery.

[1085] J. Rouleau,et al. Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. , 2014, Journal of the American College of Cardiology.

[1086] J. W. Louwerenburg,et al. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial , 2014, The Lancet.

[1087] H. Schunkert,et al. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. , 2014, European heart journal.

[1088] J. Marchesini,et al. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplas , 2014, JACC. Cardiovascular interventions.

[1089] H. White,et al. Comparison of four risk scores for contemporary isolated coronary artery bypass grafting. , 2014, Heart, lung & circulation.

[1090] Kevin L. Thomas,et al. Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surgeons CAPS‐Care Atrial Fibrillation Registry , 2014, Clinical cardiology.

[1091] A. Go,et al. Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. , 2014, Journal of the American College of Cardiology.

[1092] C. Berry,et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI) , 2014, Journal of the American College of Cardiology.

[1093] R. Lange,et al. The German Aortic Valve Registry (GARY): in-hospital outcome , 2013, European heart journal.

[1094] Hiroshi Ito,et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). , 2014, Journal of the American College of Cardiology.

[1095] P. Serruys,et al. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1096] Marco Roffi,et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial , 2014, The Lancet.

[1097] R. Califf,et al. EXTENT, LOCATION, AND CLINICAL SIGNIFICANCE OF NON-INFARCT RELATED CORONARY ARTERY DISEASE AMONG PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION , 2014 .

[1098] Eric Anderson,et al. Anticoagulation strategies for the management of postoperative atrial fibrillation. , 2014, Clinics in laboratory medicine.

[1099] A. Speir,et al. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1100] M. Jahangiri,et al. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease. , 2014, The Journal of thoracic and cardiovascular surgery.

[1101] Hongjian Zhu,et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. , 2014, Journal of the American College of Cardiology.

[1102] T. Marwick,et al. Prognostic value of stress imaging after revascularization: a systematic review of stress echocardiography and stress nuclear imaging. , 2014, American heart journal.

[1103] V. Falk,et al. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery , 2014, European heart journal.

[1104] T. Adriaenssens,et al. PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort: PRESTIGE. , 2014, European heart journal.

[1105] E. Steyerberg,et al. Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial. , 2014, Journal of the American College of Cardiology.

[1106] S. Saito,et al. A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial , 2014, European heart journal.

[1107] M. Sabatine,et al. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials , 2014, The Lancet.

[1108] B. Dimitrov,et al. Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.

[1109] P. Serruys,et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted Fro , 2014, JACC. Cardiovascular interventions.

[1110] Jeroen J. Bax,et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. , 2014, European heart journal.

[1111] C. Di Mario,et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. , 2014, European heart journal.

[1112] B. Li,et al. Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1113] P. Hartigan,et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. , 2014, JAMA internal medicine.

[1114] P. Serruys,et al. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. , 2015, Journal of the American College of Cardiology.

[1115] G. Lip,et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials , 2015, BMJ : British Medical Journal.

[1116] E. Blackstone,et al. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? , 2015, The Journal of thoracic and cardiovascular surgery.

[1117] M. Jeong,et al. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. , 2015, Journal of the American College of Cardiology.

[1118] D. van Klaveren,et al. Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials. , 2015, International journal of cardiology.

[1119] W. Cheong,et al. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. , 2015, Journal of the American College of Cardiology.

[1120] J. Chiche,et al. Immediate Percutaneous Coronary Intervention Is Associated With Improved Short- and Long-Term Survival After Out-of-Hospital Cardiac Arrest , 2015, Circulation. Cardiovascular interventions.

[1121] D. Capodanno,et al. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients , 2015, BMJ : British Medical Journal.

[1122] F. Ponziani,et al. Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1123] E. Hannan,et al. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease , 2015, Circulation. Cardiovascular interventions.

[1124] Taira Yamamoto,et al. Coronary artery bypass revascularization using bilateral internal thoracic arteries in diabetic patients: a systematic review and meta-analysis. , 2015, The Annals of thoracic surgery.

[1125] H. Schunkert,et al. Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[1126] E. Ribeiro,et al. Does Ad Hoc Coronary Intervention Reduce Radiation Exposure? – Analysis of 568 Patients , 2015, Arquivos brasileiros de cardiologia.

[1127] G. Stone,et al. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. , 2015, The American journal of cardiology.

[1128] P. Jüni,et al. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. , 2015, The New England journal of medicine.

[1129] J. Rouleau,et al. Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial , 2015, Circulation.

[1130] L. Køber,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[1131] A. Briggs,et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial , 2014, European heart journal.

[1132] A. Jeremias,et al. Long‐term outcomes following fractional flow reserve‐guided treatment of angiographically ambiguous left main coronary artery disease: A meta‐analysis of prospective cohort studies , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[1133] M. Mamas,et al. Incidence and mechanisms of longitudinal stent deformation associated with Biomatrix, Resolute, Element, and Xience stents: Angiographic and case‐by‐case review of 1,800 PCIs , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[1134] Matthias Gutberlet,et al. Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study , 2015, European heart journal.

[1135] P. Teirstein,et al. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. , 2015, The New England journal of medicine.

[1136] William Wijns,et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study , 2015, European heart journal.

[1137] R. Guyton,et al. Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. , 2015, The Journal of thoracic and cardiovascular surgery.

[1138] G. Stone,et al. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[1139] B. McNally,et al. Early Coronary Angiography and Survival After Out-of-Hospital Cardiac Arrest , 2015, Circulation. Cardiovascular interventions.

[1140] Samin K. Sharma,et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. , 2015, Journal of the American College of Cardiology.

[1141] A. Yeung,et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[1142] Sunil V. Rao,et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial , 2015, The Lancet.

[1143] Håkan Geijer,et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. , 2015, The Journal of thoracic and cardiovascular surgery.

[1144] K. Phan,et al. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1145] H. Schunkert,et al. Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial. , 2015, Journal of the American College of Cardiology.

[1146] P. Herbison,et al. Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression , 2015, BMJ Open.

[1147] D. Malenka,et al. Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program. , 2015, Circulation.

[1148] M. Togni,et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. , 2015, Journal of the American College of Cardiology.

[1149] Akiko Maehara,et al. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). , 2015, JACC. Cardiovascular interventions.

[1150] S. Garcia,et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. , 2015, The American journal of cardiology.

[1151] Sunil V. Rao,et al. Randomized trial of primary PCI with or without routine manual thrombectomy. , 2015, The New England journal of medicine.

[1152] A. Chernyavskiy,et al. Comparative results of endoscopic and open methods of vein harvesting for coronary artery bypass grafting: a prospective randomized parallel-group trial , 2015, Journal of Cardiothoracic Surgery.

[1153] A. Colombo,et al. Hybrid coronary revascularization: promising, but yet to take off. , 2015, Journal of the American College of Cardiology.

[1154] A. Albanese,et al. Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials†. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1155] D. van Klaveren,et al. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. , 2015, European heart journal.

[1156] J. Andreasen,et al. Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery , 2015, Scandinavian cardiovascular journal : SCJ.

[1157] E. Hannan,et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. , 2015, The New England journal of medicine.

[1158] Holger Thiele,et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. , 2015, The Cochrane database of systematic reviews.

[1159] K. Anstrom,et al. Three-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention: Results in 49 325 Senior Patients in the Medicare-Linked National Cardiovascular Data Registry CathPCI Registry , 2015, Circulation. Cardiovascular interventions.

[1160] P. Serruys,et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial , 2015, The Lancet.

[1161] A. Kastrati,et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis , 2015, The Lancet.

[1162] F. Eberli,et al. Polymer-free Drug-Coated Coronary Stents. , 2016, The New England journal of medicine.

[1163] T. Yan,et al. A meta-analysis of endoscopic versus conventional open radial artery harvesting for coronary artery bypass graft surgery , 2015 .

[1164] S. Saito,et al. Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent: The EVOLVE II Randomized Trial , 2015, Circulation. Cardiovascular interventions.

[1165] Patrick W Serruys,et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. , 2015, European heart journal.

[1166] A. Íñiguez,et al. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[1167] Giuseppe Biondi-Zoccai,et al. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials , 2015, The Lancet.

[1168] M. Valgimigli,et al. Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis. , 2015, International journal of cardiology.

[1169] J. Spertus,et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). , 2015, JACC. Cardiovascular interventions.

[1170] H. Swanton,et al. Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[1171] F. Burzotta,et al. Results of emergency postoperative re-angiography after cardiac surgery procedures. , 2015, The Annals of thoracic surgery.

[1172] G. Schuler,et al. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial. , 2015, JACC. Cardiovascular interventions.

[1173] T. Gerds,et al. Transit‐Time Flow Measurement as a Predictor of Coronary Bypass Graft Failure at One Year Angiographic Follow‐Up , 2015, Journal of cardiac surgery.

[1174] M. Sá,et al. Flow capacity of skeletonized versus pedicled internal thoracic artery in coronary artery bypass graft surgery: systematic review, meta-analysis and meta-regression. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1175] S. Yusuf,et al. Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. , 2015, European heart journal.

[1176] C. Di Mario,et al. Retrograde Recanalization of Chronic Total Occlusions in Europe: Procedural, In-Hospital, and Long-Term Outcomes From the Multicenter ERCTO Registry. , 2015, Journal of the American College of Cardiology.

[1177] Deborah J. Shuman,et al. Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. , 2016, The Annals of thoracic surgery.

[1178] C. Terkelsen,et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial , 2016, The Lancet.

[1179] T. Ivert,et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study , 2015, European heart journal.

[1180] F. Mohr,et al. Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction , 2016, Circulation.

[1181] R. Venkateswaran,et al. Reusing the patent internal mammary artery as a conduit in redo coronary artery bypass surgery. , 2016, Interactive cardiovascular and thoracic surgery.

[1182] B. D. de Mol,et al. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1183] Sunil V. Rao,et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. , 2016, JACC. Cardiovascular interventions.

[1184] Yundai Chen,et al. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients. , 2016, JACC. Cardiovascular interventions.

[1185] T. Vassiliades,et al. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. , 2013, Journal of the American College of Cardiology.

[1186] P. Serruys,et al. Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients , 2016, Circulation. Cardiovascular interventions.

[1187] M. Mack,et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. , 2016, The New England journal of medicine.

[1188] M. Costa,et al. Impact of Routine Fractional Flow Reserve Evaluation During Coronary Angiography on Management Strategy and Clinical Outcome: One-Year Results of the POST-IT Multicenter Registry , 2016, Circulation. Cardiovascular interventions.

[1189] David R Thompson,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[1190] Ian Graham,et al. EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE , 2005 .

[1191] B. D. de Mol,et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.

[1192] A. J. Smith,et al. Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[1193] J. Kirklin,et al. Ventricular Assist Device in Acute Myocardial Infarction. , 2016, Journal of the American College of Cardiology.

[1194] P. Serruys,et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial , 2016, The Lancet.

[1195] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1196] Xiao-Wen Wang,et al. Minimally invasive direct coronary bypass compared with percutaneous coronary intervention for left anterior descending artery disease: a meta-analysis , 2016, Journal of Cardiothoracic Surgery.

[1197] B. Uretsky,et al. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. , 2016, Journal of the American College of Cardiology.

[1198] W. Wijns,et al. Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease , 2016, Circulation.

[1199] Deepak L. Bhatt,et al. Trends in Coronary Angiography, Revascularization, and Outcomes of Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction. , 2016, The American journal of cardiology.

[1200] J. W. Louwerenburg,et al. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial , 2016, The Lancet.

[1201] A. Kastrati,et al. Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent? , 2016, European heart journal.

[1202] J. Ioannidis,et al. Meta-Analysis Comparing Established Risk Prediction Models (EuroSCORE II, STS Score, and ACEF Score) for Perioperative Mortality During Cardiac Surgery. , 2016, The American journal of cardiology.

[1203] Marc P. Bonaca,et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. , 2016, European heart journal.

[1204] Jinghua Liu,et al. Randomized Comparison of the Crush Versus the Culotte Stenting for Coronary Artery Bifurcation Lesions , 2016, Chinese medical journal.

[1205] C. Hesse,et al. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. , 2016, British journal of anaesthesia.

[1206] Sunil V. Rao,et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial , 2016, The Lancet.

[1207] G. Rioufol,et al. Routine Fractional Flow Reserve Combined to Diagnostic Coronary Angiography as a One-Stop Procedure: Episode 3. , 2016, Circulation. Cardiovascular interventions.

[1208] A. Mennander,et al. Is emergency and salvage coronary artery bypass grafting justified? The Nordic Emergency/Salvage coronary artery bypass grafting study. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[1209] G. Dangas,et al. Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial , 2016, Circulation. Cardiovascular interventions.

[1210] J. Spratt,et al. The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry. , 2016, Journal of the American College of Cardiology.

[1211] G. Rioufol,et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. , 2016, European heart journal.

[1212] T. Vassiliades,et al. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. , 2016, The Journal of thoracic and cardiovascular surgery.

[1213] O. Hlinomaz,et al. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study , 2016, Circulation. Cardiovascular interventions.

[1214] P. Serruys,et al. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. , 2016, Journal of the American College of Cardiology.

[1215] Yanyan Zhao,et al. Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention. , 2016, JACC. Cardiovascular interventions.

[1216] D. Altman,et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial. , 2016, The Journal of thoracic and cardiovascular surgery.

[1217] J. Morgan,et al. Clinical utility of carotid duplex ultrasound prior to cardiac surgery. , 2016, Journal of vascular surgery.

[1218] G. Faggian,et al. Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting. , 2016, JAMA cardiology.

[1219] Heribert Schunkert,et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials , 2016, The Lancet.

[1220] Seung‐Jung Park,et al. Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes. , 2016, Journal of the American College of Cardiology.

[1221] C. Blauth,et al. Implementation and consistency of Heart Team decision-making in complex coronary revascularisation. , 2016, International journal of cardiology.

[1222] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[1223] G. Lip,et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[1224] A. Baumbach,et al. The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations , 2016, Circulation. Cardiovascular interventions.

[1225] M. Niemelä,et al. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. , 2016, European heart journal.

[1226] P. Croisille,et al. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction: The MIMI Study , 2016, Circulation. Cardiovascular interventions.

[1227] Emilia Bagiella,et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. , 2016, The New England journal of medicine.

[1228] Patrick M. Looser,et al. Peri- and postoperative care after coronary artery bypass grafting in low versus high volume centers. , 2016, The Journal of thoracic and cardiovascular surgery.

[1229] S. Bangalore. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease , 2016, The New England journal of medicine.

[1230] F. Crea,et al. Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results. , 2016, Journal of the American College of Cardiology.

[1231] Rod S Taylor,et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. , 2016, Journal of the American College of Cardiology.

[1232] G. Cheng,et al. Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials. , 2016, International journal of cardiology.

[1233] M. Mack,et al. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years. , 2016, JACC. Cardiovascular interventions.

[1234] D. van Klaveren,et al. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials. , 2016, JACC. Cardiovascular interventions.

[1235] Erik Jørgensen,et al. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography , 2016, Circulation.

[1236] F. Fedele,et al. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. , 2016, Journal of the American College of Cardiology.

[1237] P. Serruys,et al. Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. , 2016, Journal of the American College of Cardiology.

[1238] J. Hartikainen,et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial , 2016, The Lancet.

[1239] J. Tijssen,et al. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. , 2016, Journal of the American College of Cardiology.

[1240] D. Altman,et al. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. , 2016, The New England journal of medicine.

[1241] M. Pasque,et al. Complete Coronary Revascularization Improves Survival in Octogenarians. , 2016, The Annals of thoracic surgery.

[1242] R. de Caterina,et al. Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary artery disease: A meta‐analysis of randomized and observational studies , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[1243] M. Krucoff,et al. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. , 2016, JACC. Cardiovascular interventions.

[1244] E. Hannan,et al. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery , 2016, Circulation.

[1245] S. Anderson,et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[1246] P. Serruys,et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial , 2015, European heart journal.